These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9047036)

  • 1. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
    le Tran Y; Forster C
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
    Li Q; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2001 Apr; 15(2):143-50. PubMed ID: 11468024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
    Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
    J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of angiotensin receptors mediating the neuromodulatory effects of angiotensin in the vas deferens of the rabbit.
    Hegde SS; Clarke DE
    J Pharmacol Exp Ther; 1993 May; 265(2):601-8. PubMed ID: 8496811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-(1-7) and the rat aorta: modulation by the endothelium.
    le Tran Y; Forster C
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):676-82. PubMed ID: 9388051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.
    Scott AL; Chang RS; Lotti VJ; Siegl PK
    J Pharmacol Exp Ther; 1992 Jun; 261(3):931-5. PubMed ID: 1602398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of heterologous receptor desensitization induced by angiotensin II type 1 receptor activation in isolated normal rat thoracic aorta.
    Pérez T; López RM; López P; Castillo C; Castillo EF
    Vascul Pharmacol; 2011; 54(1-2):29-35. PubMed ID: 21122823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors.
    Zwart AS; Davis EA; Widdop RE
    Br J Pharmacol; 1998 Dec; 125(7):1429-36. PubMed ID: 9884070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB; Smith RD
    Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of PD 121981- and CGP 42112-induced unmasking of low concentration effects of angiotensin II in rabbit abdominal aorta.
    Hong KW; Rhim BY; Shin YW; Yoo SE
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1591-6. PubMed ID: 7996473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tonic suppression of spontaneous baroreceptor reflex by endogenous angiotensins via AT(2) subtype receptors at nucleus reticularis ventrolateralis in the rat.
    Lin K; Chan SH; Chan JY
    Synapse; 2001 Apr; 40(1):85-94. PubMed ID: 11170225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
    Owen RA; Molon-Noblot S; Hubert MF; Siegl PK; Eydelloth RS; Keenan KP
    Lab Invest; 1994 Oct; 71(4):543-51. PubMed ID: 7967510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors.
    Maeso R; Navarro-Cid J; Muñoz-García R; Rodrigo E; Ruilope LM; Lahera V; Cachofeiro V
    Hypertension; 1996 Dec; 28(6):967-72. PubMed ID: 8952584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
    Li Q; Feenstra M; Pfaffendorf M; Eijsman L; van Zwieten PA
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):451-6. PubMed ID: 9156353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between AT1 and alpha1-adrenergic receptors in cardiomyopathic hamsters.
    Crespo MJ
    J Card Fail; 2000 Sep; 6(3):257-63. PubMed ID: 10997753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
    Ritter JM; Cockcroft JR; Sciberras DG; Goldberg MR
    J Hypertens Suppl; 1993 Apr; 11(3):S59-61. PubMed ID: 8391072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
    Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
    Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.